Irish Medicines Database · HPRA register

Abrysvo powder and solvent for solution for injection

Authorisation EU/1/23/1752/007-009 · Pfizer Europe MA EEIG

Licence EU/1/23/1752/007-009 · Unknown

Licence holder: Pfizer Europe MA EEIG (all products →)
Active substances: Respiratory syncytial virus, subgroup A, stabilized prefusion F protein 847A, Respiratory syncytial virus, subgroup B, stabilized prefusion F protein 847B
Dosage form: Powder and solvent for solution for injection
Route of administration: Intramuscular use
ATC code: J07BX05
First authorised: 23/08/2023
Prescription status: Product subject to prescription which may not be renewed (A)
Supply: Supply through pharmacies only
Legal basis: Full application (Article 8(3) of Directive No 2001/83/EC)

Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 16 Sep 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.